Maravai Lifesciences Holdings (MRVI) Income from Non-Controlling Interests (2020 - 2026)

Maravai Lifesciences Holdings' Income from Non-Controlling Interests history runs 7 years deep, the most recent figure standing at -$2.6 million for Q1 2026.

• On a quarterly basis, Income from Non-Controlling Interests rose 88.46% year-over-year to -$2.6 million in Q1 2026; TTM through Mar 2026 was -$79.7 million, a 37.26% increase from a year earlier, with the FY2025 full-year figure at -$100.0 million, up 12.88% from the prior year.
• Income from Non-Controlling Interests advanced to -$2.6 million in Q1 2026 per MRVI's latest filing, from -$27.3 million in the prior quarter.
• Across five years, Income from Non-Controlling Interests topped out at $85.5 million in Q2 2022 and bottomed at -$75.4 million in Q3 2024.
• The 5-year median for Income from Non-Controlling Interests is -$8.6 million (2024), against an average of $2.0 million.
• Across the five-year window, Income from Non-Controlling Interests tumbled 772.47% in 2024 and jumped 88.46% in 2026, its largest moves.
• Year by year, Income from Non-Controlling Interests stood at $49.8 million in 2022, then tumbled by 108.08% to -$4.0 million in 2023, then slumped by 401.17% to -$20.2 million in 2024, then tumbled by 35.57% to -$27.3 million in 2025, then soared by 90.33% to -$2.6 million in 2026.
• Per Business Quant, the three latest MRVI Income from Non-Controlling Interests figures stand at -$2.6 million (Q1 2026), -$27.3 million (Q4 2025), and -$19.5 million (Q3 2025).